Since mTORC1 signaling increases glycolysis in CD4+ T cells [13], and mTORC1 is activated in SLE CD4+ T cells [14], we tested the effect of inhibiting mTORC1 on SLE CD4+ T cell EZH2 expression. The gene discussed is EZH2; the disease is systemic lupus erythematosus.